Human clinical trials of ADSC transplant to ameliorate stroke symptoms begin in Taiwan
The Buddhist Tzu Chi Hospital in Hualien, on the east coast of Taiwan, has begun a series of three human clinical trials using ADSC transplants to ameliorate stroke symptoms in vivo, the hospital announced on November 10, 2017.
ADSCs are adipose derived stem cells. The hospital is using transplantation of ADSC, the human adipose derived stem cells, in three scheduled clinical trials to ameliorate stroke symptoms. The hospital had already completed the first phase of clinical trials using transplantation of human ADSC to ameliorate hardening of the liver.
For information about the Tzu Chi hospitals, go to: http://www.tzuchi.com.tw/